Erratum: Validation of the Chinese version of Addenbrooke's Cognitive Examination-Revised for screening mild Alzheimer's disease and mild cognitive impairment (Dementia and Geriatric Cognitive Disorders (2014) 37 (223-231) DOI: 10.1159/000353541);Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 37, Issue 3-4, 2014, Pages 223-231

  Fang, Rong ^a   Wang, Gang ^a   Huang, Yue ^b   Zhuang, Jun Peng ^a   Tang, Hui Dong ^a   Wang, Ying ^a   Deng, Yu Lei ^a   Xu, Wei ^a   Chen, Sheng Di ^a   Ren, Ru Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Addenbrooke's Cognitive Examination Revised; Alzheimer's disease; Chinese; Mild cognitive impairment; Mini Mental State Examination; Screening

Indexed keywords

ADDENBROOKE COGNITIVE EXAMINATION REVISED; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SENSITIVITY AND SPECIFICITY; VALIDITY; ASIAN CONTINENTAL ANCESTRY GROUP; DIFFERENTIAL DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PSYCHOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS; VALIDATION STUDY; VERY ELDERLY; ATTENTION; CHINESE VERSION OF ADDENBROOKE COGNITIVE EXAMINATION REVISED; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEPTH PERCEPTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; LANGUAGE; MEMORY; ORIENTATION; RECALL; TEST RETEST RELIABILITY; TRACHEOBRONCHIAL STENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84886742401     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000357926     Document Type: Erratum

References (36)

1. Naylor MD, Karlawish JH, Arnold SE, et al: Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimers Dement 2012; 8: 445-452.
2. Petersen RC, Roberts RO, Knopman DS, et al: Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447-1455.
3. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
4. Petersen RC, Morris JC: Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005; 62: 1160-1163.
5. Ellison JM: A 60-year-old woman with mild memory impairment: review of mild cognitive impairment. JAMA 2008; 300: 1566-1574.
6. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
7. Ahmed S, de Jager C, Wilcock G: A comparison of screening tools for the assessment of mild cognitive impairment: preliminary findings. Neurocase 2012; 18: 336-351.
8. Mauri M, Sinforiani E, Zucchella C, et al: Progression to dementia in a population with amnestic mild cognitive impairment: clinical variables associated with conversion. Funct Neurol 2012; 27: 49-54.
9. Mioshi E, Dawson K, Mitchell J, et al: The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-1085.
10. Lischka AR, Mendelsohn M, Overend T, et al: A systematic review of screening tools for predicting the development of dementia. Can J Aging 2012; 31: 295-311.
11. Lonie JA, Tierney KM, Ebmeier KP: Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 2009; 24: 902-915.
12. Ferreira IS, Simões MR, Marôco J: The Addenbrooke's Cognitive Examination Revised as a potential screening test for elderly drivers. Accid Anal Prev 2012; 49: 278-286.
13. Kwak YT, Yang Y, Kim GW: Korean Addenbrooke's Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer's disease and subcortical ischemic vascular dementia. Geriatr Gerontol Int 2010; 10: 295-301.
14. Konstantinopoulou E, Kosmidis MH, Ioannidis P, et al: Adaptation of Addenbrooke's Cognitive Examination-Revised for the Greek population. Eur J Neurol 2011; 18: 442-447.
15. Terpening Z, Cordato NJ, Hepner IJ, et al: Utility of the Addenbrooke's Cognitive Examination-Revised for the diagnosis of dementia syndromes. Australas J Ageing 2011; 30: 113-118.
16. Torralva T, Roca M, Gleichgerrcht E, et al: Validation of the Spanish version of the Addenbrooke's Cognitive Examination-Revised (ACE-R). Neurologia 2011; 26: 351-356.
17. Alexopoulos P, Ebert A, Richter-Schmidinger T, et al: Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in Alzheimer's disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2010; 29: 448-456.
18. Dos Santos Kawata KH, Hashimoto R, Nishio Y, et al: A validation study of the Japanese version of the Addenbrooke's Cognitive Examination-Revised. Dement Geriatr Cogn Dis Extra 2012; 2: 29-37.
19. Alexopoulos P, Greim B, Nadler K, et al: Validation of the Addenbrooke's cognitive examination for detecting early Alzheimer's disease and mild vascular dementia in a German population. Dement Geriatr Cogn Disord 2006; 22: 385-391.
20. Pigliautile M, Ricci M, Mioshi E, et al: Validation study of the Italian Addenbrooke's Cognitive Examination Revised in a young-old and old-old population. Dement Geriatr Cogn Disord 2011; 32: 301-307.
21. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
22. Guo Q, Zhao Q, Chen M, et al: A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord 2009; 23: 253-259.
23. Roberts RO, Geda YE, Knopman DS, et al: The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008; 30: 58-69.
24. Macklin EA, Blacker D, Hyman BT, et al: Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints. J Alzheimers Dis 2013; 36: 475-486.
25. Pagonabarraga J, Gómez-Ansón B, Rotger R, et al: Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Dement Geriatr Cogn Disord 2012; 34: 312-318.
26. Roberts RO, Knopman DS, Geda YE, et al: Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 2013, DOI: 10.1016/j.jalz.2013.01.001.
27. Chan KW, Lee TM, Siu AM, et al: Effects of chronic ketamine use on frontal and medial temporal cognition. Addict Behav 2013; 38: 2128-2132.
28. Mortimer JA, Ding D, Borenstein AR, et al: Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders. J Alzheimers Dis 2012; 30: 757-766.
29. Zhao S, Guo C, Wang M, et al: A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly Chinese population. J Clin Neurosci 2011; 18: 774-779.
30. Carter SF, Caine D, Burns A, et al: Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease. Int J Geriatr Psychiatry 2012; 27: 423-432.
31. Yoshida H, Terada S, Honda H, et al: Validation of the revised Addenbrooke's Cognitive Examination (ACE-R) for detecting mild cognitive impairment and dementia in a Japanese population. Int Psychogeriatr 2012; 24: 28-37.
32. Crawford S, Whitnall L, Robertson J, et al: A systematic review of the accuracy and clinical utility of the Addenbrooke's Cognitive Examination and the Addenbrooke's Cognitive Examination-Revised in the diagnosis of dementia. Int J Geriatr Psychiatry 2012; 27: 659-669.
33. Raimondi C, Gleichgerrcht E, Richly P, et al: The Spanish version of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in subcortical ischemic vascular dementia. J Neurol Sci 2012; 322: 228-231.
34. Budson AE, Solomon PR: New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist. Pract Neurol 2012; 12: 88-96.
35. Lunnon K, Sattlecker M, Furney SJ, et al: A blood gene expression marker of early Alzheimer's disease. J Alzheimers Dis 2013; 33: 737-753.
36. Zhang N, Song X, Zhang Y: Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2012; 33: 318-326.